D2B3 is a pre-clinical biotechnology company dedicated to advancing drug delivery solutions to the brain and central nervous system.
Its proprietary technology allows to transiently and specifically open the blood brain barrier for therapeutic targeting of CNS diseases with high efficacy. Our approach is plug-and-play and works with most drugs and therapeutic classes.
Company Details
- Address
- 101 College St, New Haven,connecticut 06510,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://d2b3.bio
- HQ
- New Haven, Connecticut
D2b3 Questions
D2B3's website is https://d2b3.bio
D2B3's LinkedIn profile is https://www.linkedin.com/company/d2b3
D2B3's industry is
Biotechnology Research
D2B3's top competitors are
Rho Bio,
Massbio,
Arvinas,
Stradefy Biosciences,
Lybra Bio,
Redpoint Oncology, Inc,
Halda Therapeutics,
Ensight-Ai,
Modulate Bio,
Bexorg, Inc..
D2B3's categories are Biotechnology Research
